Company Cash Funds: Pheton Holdings Ltd (PTHL)

Official company branding of Pheton Holdings (PTHL)

Pheton Holdings Ltd revenue stability is based on the deep integration of radiotherapy software into medical centers. Revenue growth is driven by the expansion of IT solutions in Asia and SaaS subscriptions, as confirmed by the cash flow history, where the latest parameter stands at 0.00. Operational efficiency and production safety are ensured by the automation of drug dosing and packaging processes through robotics.

Pheton Holdings Ltd - PTHL Company Cash Balance (period 09/06/2024 - 01/16/2026)

Summary analytical data breakdowns for ftzy.com.cn (PTHL)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
General company analysis:ftzy.com.cn
Signature product of Pheton Holdings Ltd

This indicator measures the company's actual liquidity, allowing for the separation of paper profits from real cash available for operational activities. Analyzing the cash balance chart is critically important for Pheton Holdings Ltd (PTHL), as reliance on Chinese government funding and regulatory risks could trigger a sharp capital deficit in the event of payment delays or product registration lags.

Who Pheton Holdings Ltd competes with

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance